Antithrombotic strategies in gene therapy.

Journal article

Advances in the field of molecular medicine are making gene therapy a viable treatment strategy for the next millennium. Indeed, over the past 10 years, a number of improvements have occurred that have resulted in an increased interest in gene therapy for the treatment of diseases in cardiovascular medicine. Because antithrombotic and anticoagulation therapy generally involves the systemic administration of agents that target a small region of the vasculature, localized and controlled deliver...

Expand abstract

Authors: Channon, K; Annex, B

• Journal: Current cardiology reports
• Volume: 2
• Issue: 1
• Pages: 34-38
• Publication date: 2000-01-01
• DOI: 10.1007/s11886-000-0023-4
• EISSN: 1534-3170
• ISSN: 1523-3782
• Language: English
• Keywords: Vascular Endothelial Growth Factors; Nitric Oxide Synthase; Protein Isoforms; Humans; Gene Therapy; Endothelial Growth Factors; Coronary Thrombosis; Lymphokines; Vascular Endothelial Growth Factor A; Animals; Thrombosis; Endothelium, Vascular; Venous Thrombosis